MedPath

Predictors and Outcomes of In-hospital HFpEF in AMI Patients

Conditions
Acute Myocardial Infarction
Predictor
Prognosis
Heart Failure With Preserved Ejection Fraction
Registration Number
NCT03351179
Lead Sponsor
Xiangjun Yang
Brief Summary

This retrospective observation is to investigate the incidence,clinical outcomes and prognosis of hospitalized heart failure with preserved ejection fraction (HFpEF) in patients with acute myocardial infarction(AMI).

Detailed Description

1. Patients with first AMI undergoing primary percutaneous coronary intervention (PCI) in our hospital since January 2013 were retrospectively evaluated. The enrolled subjects were divided into two groups (AMI patients with HFpEF and AMI patients without HF).

2. The investigator collected the clinical data of participants' demographics (age, sex), previous history,risk factors for AMI (hypertension, hyperlipidemia, diabetes mellitus, smoking and stroke), laboratory biomarkers, echocardiographic measurements, clinical characteristics,medical procedures and treatments, as well as in-hospital complications.

3. Two sub-investigators independently analyzed these data by using SPSS software.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  • First AMI patients undergoing PCI with HFpEF or without HF.
Exclusion Criteria
  • First AMI patients with heart failure with reduced ejection fraction.
  • First AMI patients with severe inflammatory diseases, valvular heart disease, non-cardiac caused symptoms, serious hepatic and renal failure, congenital cardiomyopathy,or pericardial diseases.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Risk factors of incident in-hospital HFpEFOutcome measure will be assessed at discharge, and data will be reported through study completion, an average of 1 year.
Secondary Outcome Measures
NameTimeMethod
Clinical prognosis in patients with HFpEFOutcome measure will be assessed at discharge, and data will be reported through study completion, an average of 1 year.

Trial Locations

Locations (1)

the First Affiliated Hospital of Soochow University

🇨🇳

Suzhou, Jiangsu, China

the First Affiliated Hospital of Soochow University
🇨🇳Suzhou, Jiangsu, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.